Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,391,535,466
-$237,414,620 QoQ
Shares Held
18,611,171
-14.8% QoQ
Ownership
0.754%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#19
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. MRK ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,391,535,466 | 18,611,171 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,628,950,086 | 21,855,101 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,162,691,421 | 20,546,185 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,665,585,466 | 19,844,936 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,347,554,124 | 17,023,170 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,373,160,496 | 15,298,134 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,537,188,823 | 15,452,240 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,431,344,980 | 12,604,306 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,955,589,481 | 15,796,361 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,118,924,210 | 16,058,539 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,826,914,632 | 16,757,610 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,819,416,496 | 17,672,817 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,469,642,538 | 21,402,570 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,015,791,851 | 18,947,193 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,988,418,042 | 17,921,749 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,520,101,611 | 17,650,971 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,772,918,339 | 19,446,291 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,644,868,154 | 20,047,144 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,548,214,517 | 20,201,129 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,461,737,481 | 19,461,290 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,071,150,853 | 13,773,317 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $865,057,877 | 11,221,396 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,248,094,832 | 15,257,890 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,285,575,033 | 15,498,185 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,270,304,318 | 16,427,050 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,351,926,555 | 17,571,187 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||